Amgen reacquires rights to three drugs from Glaxo in 48 countries

(Reuters) - Amgen Inc on Monday said it had reached a deal with British drugmaker GlaxoSmithKline to reacquire the sales rights to three of its products in 48 countries, including Australia as well as markets in Asia, South America and Europe.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro